Amanote Research
Register
Sign In
Are Changes in the Pharmacokinetic (PK) and Pharmacodynamic (PD) Properties of Antipsychotics Able to Improve Efficacy and Safety?
Annals of General Psychiatry
- United Kingdom
doi 10.1186/1744-859x-7-s1-s77
Full Text
Open PDF
Abstract
Available in
full text
Categories
Psychiatry
Mental Health
Date
April 1, 2008
Authors
Luca Pani
Publisher
Springer Science and Business Media LLC
Related search
Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Anti-Neoplastic Agents
Population Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Depot Testosterone Cypionate in Healthy Male Subjects
Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: A Step Toward Model-Based Dose Optimization
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Erratum to Tianeptine: A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Depression and Coexisting Anxiety and Depression
Drugs
Pharmacology
Erratum to a Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in the Treatment of Arrhythmias
Drugs
Pharmacology
Evaluation of Pharmacokinetic, Pharmacodynamic, Efficacy, and Safety Data of Low-Dose Ticagrelor Versus Standard Dose in East Asians: A Systematic Review
Therapeutics and Clinical Risk Management
Efficacy, Pharmacokinetic and Pharmacodynamic Evaluation of Apaziquone in the Treatment of Non-Muscle Invasive Bladder Cancer
Expert Opinion on Drug Metabolism and Toxicology
Medicine
Toxicology
Pharmacology
Benchmark Problem: A PK/PD Model and Safety Constraints for Anesthesia Delivery
Comprehensive Assessment of the Pharmacokinetic Properties of a Single Bolus Dose of Colecalciferol in Terms of Efficacy and Safety
Osteoporosis and Bone Diseases
